Happe, M., Hofstetter, A. R., Wang, J., Yamshchikov, G. V., Holman, L. A., Novik, L., . . . team, t. V. 2. a. R. 4. s. Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials. Nature Portfolio.
Chicago Style (17th ed.) CitationHappe, Myra, et al. Heterologous CAd3-Ebola and MVA-EbolaZ Vaccines Are Safe and Immunogenic in US and Uganda Phase 1/1b Trials. Nature Portfolio.
MLA (9th ed.) CitationHappe, Myra, et al. Heterologous CAd3-Ebola and MVA-EbolaZ Vaccines Are Safe and Immunogenic in US and Uganda Phase 1/1b Trials. Nature Portfolio.
Warning: These citations may not always be 100% accurate.